AN2 Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 11/08/2026 | Mar 2026Filed 11/08/2026 | Sep 2025Filed 12/11/2025 | Jun 2025Filed 11/08/2026 | Mar 2025Filed 11/08/2026 | Sep 2024Filed 12/11/2025 | Jun 2024Filed 12/11/2025 | Mar 2024Filed 12/11/2025 |
|---|---|---|---|---|---|---|---|---|
| −$8.2 | −$10 | −$9.4 | −$6.5 | −$11 | −$13 | −$14 | −$17 | |
| −$0.18 | −$0.29 | −$0.31 | −$0.21 | −$0.35 | −$0.43 | −$0.48 | −$0.56 | |
| 45 | 34 | 30 | 30 | 30 | 30 | 30 | 30 |
Trend